Correspondence 0001213900-23-057763 from ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
ENZO BIOCHEM INC (ENZ) (CIK 0000316253)
Date: July 18, 2023 · CIK: 0000316253 · Accession: 0001213900-23-057763
AI Filing Summary & Sentiment
File numbers found in text: 333-272727
Show Raw Text
CORRESP
1
filename1.htm
Enzo Biochem, Inc.
81 Executive Blvd.,
Suite 3
Farmingdale, NY,
11735
July 18, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE:
Enzo Biochem, Inc. (CIK 000316253)
Registration Statement No. 333-272727 on Form S-3 (the “Registration Statement”)
Ladies and Gentlemen:
Enzo
Biochem, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration
Statement pursuant to Rule 461 under the Securities Act of 1933, as amended, so that it may become effective on July 18, 2023 at 5:30
p.m., Eastern Time, or as soon thereafter as is practicable.
The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our
counsel, McDermott Will & Emery LLP, by calling Dan Woodard at (212) 547-5553. The Registrant hereby authorizes Mr. Woodard to
orally modify or withdraw this request for acceleration.
Very truly yours,
Enzo Biochem, Inc.
By:
/s/ Hamid Erfanian
Hamid Erfanian
Chief Executive Officer